Error: Could not add to watchlist. X

Regulus Therapeutics Inc

+ Watchlist
RGLS:US
NASDAQ GM
10.34
USD
0.62
5.66%
As of 12:57:21 ET on 07/01/2015.
Open
11.08
Day Range
10.25 - 11.32
Volume
385,739
Previous Close
10.96
52Wk Range
6.13 - 25.60
1 Yr Return
27.31%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-1.12
Market Cap (m USD)
524.459
Shares Outstanding (m)
51.017
Price/Sales (TTM)
48.05
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Regulus Therapeutics Inc. operates within the biopharmaceutical industry. The Company's products aim to treat or prevent hepatitis C infections, cardiovascular disease, fibrosis, oncology, immuno-inflammatory diseases, and metabolic diseases. Regulas's research consists of scientists from across the world.
ADDRESS
1896 Rutherford Road
Carlsbad, CA 92008-7208
United States
PHONE
1-800-734-8587
  • Paul C Grint
    President/CEO
  • David Szekeres
    CFO/CAO/General Counsel
  • Amy Conrad
    Senior Dir:Investor Relations
Show More